Abstract:Nanoparticles (NPs) derived from branched copolymers of poly (β-L-malic acid) (PMLA) have been extensively investigated for drug delivery due to their high density of pendant carboxyl groups. This abundant functional group availability enhances their potential as effective drug delivery systems; however, the strong negative charge of PMLA poses a challenge in its uptake by cancer cells due to electrostatic repulsion. In this study, we developed novel enzyme- and pH-sensitive nanoparticles (EP-NPs) based on PMLA, demonstrating tumor-specific behavior and selective activation within tumor tissues. To enhance the cellular internalization of the nanoparticles, we incorporated transactivator of transcription (TAT). In summary, long-chain polyethylene glycol (PEG) was conjugated to PMLA to confer specificity to the TAT peptide. This was achieved using a tetrapeptide linker: alanine-alanine-asparagine-leucine (AANL), which serves as a substrate for legumain. Legumain is a highly conserved cysteine protease primarily found in lysosomes and blood vessels, initially discovered in legumes. It is markedly overexpressed in numerous solid tumors, as well as in endothelial cells and tumor-associated macrophages. The release of doxorubicin in tumor cells was sustained due to the low pH (5.0-5.5) and degradation of PMLA. The PEG modification optimized the particle size and shielded the nanoparticles from plasma proteins and detection by the reticuloendothelial system, thereby prolonging their long circulation time. Once the nanoparticles reached the tumor microenvironment, the AANL was cleaved by legumain, exposing the TAT peptide on the surface, which enhances cellular internalization. Both in vitro and in vivo efficacy studies demonstrated that these EP-NPs significantly inhibited tumor growth while exhibiting negligible systemic toxicity, thereby suggesting that the developed enzyme/pH-sensitive PMLA-based nanoparticle holds great promise as an anti-tumor drug delivery system.

TAT-conjugated Poly (Β-Malic Acid)-Poly (ethylene Glycol) Nanoconjugate：synthe-Sis and Biological Evaluation

Optimal Design of Novel Functionalized Nanoconjugates Based on Polymalic Acid for Efficient Tumor Endocytosis with Enhanced Anticancer Activity.

Study on preparation and characterization of poly(β-malic-acid)-doxorubicin/do-cetaxel nanoconjugate

Preparation and Biological Evaluation of a Novel Ph-Sensitive Poly (Β-Malic Acid) Conjugate for Antitumor Drug Delivery.

Prodrug of Poly(β-malic acid)-Hydroxycamptothecin Polymer:Preparation,Characterization and Biological Evaluation

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy

Enzyme/pH-sensitive nanoparticles based on poly(β-L-malic acid) for drug delivery with enhanced endocytosis

Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery

Ratiometric Co-Delivery of Doxorubicin and Docetaxel by Covalently Conjugating with Mpeg-Poly(β-malic Acid) for Enhanced Synergistic Breast Tumor Therapy

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Enhanced Endocytic and Ph-Sensitive Poly(malic Acid) Micelles for Antitumor Drug Delivery

Building Stable Mmp2-Responsive Multifunctional Polymeric Micelles by an All-In-One Polymer-Lipid Conjugate for Tumor-Targeted Intracellular Drug Delivery

Synthesis of Controlled Molecular Weight Poly (Β-Malic Acid) and Conjugation with HCPT As a Polymeric Drug Carrier

Dimeric Drug Polymeric Micelles with Acid-Active Tumor Targeting and FRET-indicated Drug Release

Synthesis, Characterization, and in Vivo Efficacy Evaluation of PGG–docetaxel Conjugate for Potential Cancer Chemotherapy

MMP-2 sensitive poly(malic acid) micelles stabilized by - stacking enable high drug loading capacity

Targeted Delivery of Cargoes into A Murine Solid Tumor by A Cell-Penetrating Peptide and Cleavable Poly(Ethylene Glycol) Comodified Liposomal Delivery System Via Systemic Administration

Peptide-Conjugated Pamam for Targeted Doxorubicin Delivery to Transferrin Receptor Overexpressed Tumors

Plasmid Porf-Htrail and Doxorubicin Co-Delivery Targeting to Tumor Using Peptide-Conjugated Polyamidoamine Dendrimer

Acid-active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery.

Tumor Cells-Specific Targeting Delivery Achieved by A54 Peptide Functionalized Polymeric Micelles